A detailed history of State Street Corp transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, State Street Corp holds 5,392,862 shares of BBIO stock, worth $137 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,392,862
Previous 5,086,899 6.01%
Holding current value
$137 Million
Previous $205 Million 18.8%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $8.37 Million - $12.4 Million
305,963 Added 6.01%
5,392,862 $167 Million
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $1.12 Million - $2.04 Million
46,485 Added 0.92%
5,086,899 $205 Million
Q3 2023

Nov 14, 2023

SELL
$16.89 - $35.01 $34.3 Million - $71 Million
-2,028,946 Reduced 28.7%
5,040,414 $133 Million
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $25.6 Million - $34.7 Million
1,926,347 Added 37.46%
7,069,360 $122 Million
Q1 2023

May 15, 2023

SELL
$7.17 - $18.55 $26.5 Million - $68.7 Million
-3,701,930 Reduced 41.85%
5,143,013 $85.3 Million
Q4 2022

Feb 14, 2023

BUY
$6.74 - $11.52 $6.08 Million - $10.4 Million
902,132 Added 11.36%
8,844,943 $67.4 Million
Q3 2022

Nov 15, 2022

SELL
$7.94 - $12.36 $23.9 Million - $37.3 Million
-3,014,252 Reduced 27.51%
7,942,811 $79 Million
Q2 2022

Aug 15, 2022

BUY
$5.21 - $12.14 $9.12 Million - $21.3 Million
1,750,829 Added 19.02%
10,957,063 $99.5 Million
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $41.7 Million - $97.5 Million
5,683,771 Added 161.36%
9,206,234 $93.4 Million
Q4 2021

Feb 14, 2022

BUY
$11.38 - $53.41 $4.99 Million - $23.4 Million
438,604 Added 14.22%
3,522,463 $58.8 Million
Q3 2021

Nov 15, 2021

BUY
$46.87 - $64.24 $20.2 Million - $27.6 Million
430,363 Added 16.22%
3,083,859 $145 Million
Q2 2021

Aug 16, 2021

BUY
$46.47 - $63.93 $13.4 Million - $18.4 Million
288,124 Added 12.18%
2,653,496 $162 Million
Q1 2021

May 17, 2021

BUY
$55.47 - $72.35 $3.82 Million - $4.98 Million
68,849 Added 3.0%
2,365,372 $146 Million
Q4 2020

Feb 16, 2021

SELL
$38.38 - $71.11 $2.23 Million - $4.12 Million
-57,985 Reduced 2.46%
2,296,523 $163 Million
Q3 2020

Nov 10, 2020

SELL
$27.2 - $42.19 $22.6 Million - $35.1 Million
-831,813 Reduced 26.11%
2,354,508 $88.3 Million
Q2 2020

Aug 14, 2020

BUY
$22.22 - $35.69 $32.7 Million - $52.6 Million
1,472,605 Added 85.93%
3,186,321 $104 Million
Q1 2020

May 11, 2020

BUY
$16.11 - $36.23 $27.6 Million - $62.1 Million
1,713,716 New
1,713,716 $49.7 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.76B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.